CXCR3 and cancer: Indeed, cancer cells with higher CXCL10 expression more effectively stimulated migration of CXCR3+ Tregs in a transwell experiment, and the CXCR3 inhibitor AMG487 reduced the number of Tregs recruited to tumors in a mouse model [127].